Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study

H Yimer, J Melear, E Faber… - British journal of …, 2019 - Wiley Online Library
Summary This United States community study evaluated the combination of daratumumab,
bortezomib, cyclophosphamide and dexamethasone (D‐VCd) in newly diagnosed multiple …
被引用次数：62 相关文章

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study.

H Yimer, J Melear, E Faber, WI Bensinger… - British Journal of …, 2019 - europepmc.org
Summary This United States community study evaluated the combination of daratumumab,
bortezomib, cyclophosphamide and dexamethasone (D‐VCd) in newly diagnosed multiple …

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study.

H Yimer, J Melear, E Faber… - British journal of …, 2019 - digitalcommons.providence.org
Abstract This United States community study evaluated the combination of daratumumab,
bortezomib, cyclophosphamide and dexamethasone (D-VCd) in newly diagnosed multiple …
[HTML] nih.gov

[HTML][HTML] Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study

H Yimer, J Melear, E Faber, WI Bensinger… - British Journal of …, 2019 - ncbi.nlm.nih.gov
Summary This United States community study evaluated the combination of daratumumab,
bortezomib, cyclophosphamide and dexamethasone (D‐VCd) in newly diagnosed multiple …

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study

H Yimer, J Melear, E Faber… - British journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
This United States community study evaluated the combination of daratumumab,
bortezomib, cyclophosphamide and dexamethasone (D-VCd) in newly diagnosed multiple …

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study.

H Yimer, J Melear, E Faber… - British journal of …, 2019 - digitalcommons.providence.org
Abstract This United States community study evaluated the combination of daratumumab,
bortezomib, cyclophosphamide and dexamethasone (D-VCd) in newly diagnosed multiple …